Table 3.
General demographics and family history of cancer in the Asian cohort (full analysis set)
| Overall (N = 104) |
gBRCA1/2m-positive (N = 11) |
gBRCA1/2m-negative (N = 93) |
|
|---|---|---|---|
| Age at enrollment, years | 53.0 (25–87) | 45.0 (25–54) | 55.0 (36–87) |
| Age at breast cancer diagnosis, years |
48.0 (24–86) (n = 101) |
36.6 (24–51) (n = 9) |
49.5 (24–86) (n = 92) |
| Post-menopausal at enrollment |
73 (70.9) (n = 103) |
4 (36.4) (n = 11) |
69 (75.0) (n = 92) |
| Nicotine use, never |
85 (85.9) (n = 99) |
5 (50.0) (n = 10) |
80 (89.9) (n = 89) |
| ECOG PSa | |||
| 0 | 71 (68.3) | 9 (81.8) | 62 (66.7) |
| 1 | 26 (25.0) | 2 (18.2) | 24 (25.8) |
| 2 | 7 (6.7) | 0 | 7 (7.5) |
| Family history of breast/ovarian cancer | 15 (14.4) | 6 (54.5) | 9 (9.7) |
ECOG PS Eastern Cooperative Oncology Group—Performance Status
Values presented are median (range) or n (%).
The number of patients with available data is provided where it differs from the overall number of patients. Percentages are based on the number of patients with available data
aAt initiation of first-line systemic cytotoxic chemotherapy